Combined Effect of Obstructive Sleep Apnea and Preserved Ratio Impaired Spirometry on Cardiovascular Outcomes
Journal of the American Heart Association · 20.10.2026 · 15 (20)
DOI: 10.1161/jaha.126.052921 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 20.10.2026. Verfasst von Lida Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Diseases Mayo Clinic Rochester MN USA. Hauptthemen laut MEDLINE: Sleep Apnea, Obstructive, Spirometry, Cardiovascular Diseases, Pulmonary Disease, Chronic Obstructive. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Background
Obstructive sleep apnea (OSA)–chronic obstructive pulmonary disease overlap syndrome has been linked to worse cardiovascular outcomes. Preserved ratio impaired spirometry (PRISm) is recognized as an early stage of chronic obstructive pulmonary diseas. However, whether the coexistence of OSA and PRISm confers increased cardiovascular risk remains unknown.
Methods
Using data from the Sleep Heart Health Study, participants were categorized into 4 groups according to OSA and PRISm status. The primary outcome was major adverse cardiovascular and cerebrovascular events. The secondary outcome was cardiovascular disease mortality. Multivariable Cox regression models were used to evaluate the association of these groups with the risk of cardiovascular outcomes.
Results
During a median follow‐up of 11.45 years, the incidence of major adverse cardiovascular and cerebrovascular events was 17.00% in non‐OSA with normal lung function, 27.52% in non‐OSA with PRISm, 25.28% in OSA with normal lung function, and 49.40% in OSA with PRISm. After multivariable adjustment, compared with non‐OSA with normal lung function, the adjusted hazard ratios (HRs) for major adverse cardiovascular and cerebrovascular events were 1.20 (95% CI, 0.82–1.75) in non‐OSA with PRISm, 1.04 (95% CI, 0.89–1.21) in OSA with normal lung function, and 1.52 (95% CI, 1.08–2.12) in OSA with PRISm. Corresponding HRs for CVD mortality were 2.02 (95% CI, 1.26–3.24), 1.05 (95% CI, 0.81–1.35), and 2.17 (95% CI, 1.41–3.34), respectively. A significant sex interaction was observed ( P for interaction=0.009), with the association present only in women.
Conclusions
The coexistence of OSA and PRISm is independently associated with increased risk of adverse cardiovascular outcomes. This association is observed predominantly in women.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Diseases Mayo Clinic Rochester MN USA.
- Department of Respiratory and Critical Care Medicine Zhangzhou Affiliated Hospital of Fujian Medical University Zhangzhou Fujian Province China.
- Department of Intensive Care Unit Tianjin 1st Center Hospital Tianjin China.
- Department of Pharmaceutics, Faculty of Pharmacy University of Sadat City Sadat City Egypt.
ORCID-Profile: Lida Chen, Yunzhou Dong, Shahid Karim, Jingjing Wang, Isra H Ali, Virend K Somers
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Chen, L., Dong, Y., Karim, S., Wang, J., Ali, I. H., & Somers, V. K. (2026). Combined Effect of Obstructive Sleep Apnea and Preserved Ratio Impaired Spirometry on Cardiovascular Outcomes. Journal of the American Heart Association, 15(20). https://doi.org/10.1161/jaha.126.052921
Vancouver
Chen L, Dong Y, Karim S, Wang J, Ali IH, Somers VK. Combined Effect of Obstructive Sleep Apnea and Preserved Ratio Impaired Spirometry on Cardiovascular Outcomes. Journal of the American Heart Association. 2026;15(20). doi:10.1161/jaha.126.052921
BibTeX
@article{Chen2026,
author = {Chen, Lida and Dong, Yunzhou and Karim, Shahid and Wang, Jingjing and Ali, Isra H and Somers, Virend K},
title = {Combined Effect of Obstructive Sleep Apnea and Preserved Ratio Impaired Spirometry on Cardiovascular Outcomes},
journal = {Journal of the American Heart Association},
year = {2026},
volume = {15},
number = {20},
doi = {10.1161/jaha.126.052921}
}
EUVIMED